​

Werewolf Therapeutics (HOWL) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChart

HOWL Stock Forecast

Werewolf Therapeutics (HOWL) stock forecast, based on 9 Wall Street analysts, predicts a 12-month average price target of $12.00, with a high of $12.00 and a low of $12.00. This represents a 1311.76% increase from the last price of $0.85.

- $3 $6 $9 $12 $15 High: $12 Avg: $12 Low: $12 Last Closed Price: $0.85

HOWL Stock Rating

Werewolf Therapeutics stock's rating consensus is Buy, based on 9 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 9 Buy (100.00%), 0 Hold (0.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 9 0 9 Strong Sell Sell Hold Buy Strong Buy

HOWL Price Target Upside V Benchmarks

TypeNameUpside
StockWerewolf Therapeutics1311.76%
SectorHealthcare Stocks 33.91%
IndustryBiotech Stocks 83.49%

Price Target Trends

1M3M12M
# Anlaysts---
Avg Price Target---
Last Closing Price$0.85$0.85$0.85
Upside/Downside---
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Apr, 2524---6
Mar, 2524---6
Feb, 2524---6
Jan, 2524---6
Dec, 2424---6
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Apr 03, 2024Reni BenjaminJMP Securities$12.00$6.0698.02%1311.76%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Jun 26, 2024H.C. WainwrightUnderperformUnderperformhold
Jun 26, 2024H.C. WainwrightBuyBuyhold
May 06, 2024H.C. WainwrightUnderperformUnderperformhold
Apr 03, 2024JMP SecuritiesMarket OutperformOutperforminitialise
Apr 03, 2024JMP SecuritiesMarket Outperforminitialise
Aug 24, 2023WedbushOutperforminitialise
May 11, 2022SVB LeerinkOutperformOutperformhold
Apr 26, 2022Zacks Investment ResearchHoldupgrade

Financial Forecast

EPS Forecast

Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-1.79$-1.05$-1.63----
Avg Forecast$-2.08$-1.11$-1.54$-1.83$-1.64$-1.90$-1.70
High Forecast$-2.08$-0.97$-1.30$-0.94$-0.77$-1.36$-1.70
Low Forecast$-2.08$-1.22$-1.95$-4.00$-3.36$-3.15$-1.70
Surprise %-13.94%-5.41%5.84%----

Revenue Forecast

$0 $15M $30M $45M $60M $75M Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$16.40M$19.94M$1.89M----
Avg Forecast$11.86M$20.37M$1.88M$2.52M$16.67M$11.60M$73.09M
High Forecast$11.86M$24.06M$2.45M$2.52M$16.67M$11.60M$73.09M
Low Forecast$11.86M$18.92M$1.60M$2.52M$16.67M$11.60M$73.09M
Surprise %38.27%-2.11%0.14%----

Net Income Forecast

$-150M $-120M $-90M $-60M $-30M $0 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-51.56M$-37.37M$-70.52M----
Avg Forecast$-74.07M$-37.37M$-62.12M$-100.38M$-73.60M$-80.48M$-60.69M
High Forecast$-74.07M$-34.75M$-46.30M$-33.33M$-27.47M$-48.63M$-60.69M
Low Forecast$-74.07M$-43.35M$-69.45M$-142.61M$-119.74M$-112.33M$-60.69M
Surprise %-30.39%-13.52%----

HOWL Forecast FAQ

Is Werewolf Therapeutics stock a buy?

Werewolf Therapeutics stock has a consensus rating of Buy, based on 9 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 9 Buy, 0 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Werewolf Therapeutics is a favorable investment for most analysts.

What is Werewolf Therapeutics's price target?

Werewolf Therapeutics's price target, set by 9 Wall Street analysts, averages $12 over the next 12 months. The price target range spans from $12 at the low end to $12 at the high end, suggesting a potential 1311.76% change from the previous closing price of $0.85.

How does Werewolf Therapeutics stock forecast compare to its benchmarks?

Werewolf Therapeutics's stock forecast shows a 1311.76% upside, outperforming the average forecast for the healthcare stocks sector (33.91%) and outperforming the biotech stocks industry (83.49%).

What is the breakdown of analyst ratings for Werewolf Therapeutics over the past three months?

  • April 2025: 33.33% Strong Buy, 66.67% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • March 2025: 33.33% Strong Buy, 66.67% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • February 2025: 33.33% Strong Buy, 66.67% Buy, 0% Hold, 0% Sell, 0% Strong Sell.

What is Werewolf Therapeutics’s EPS forecast?

Werewolf Therapeutics's average annual EPS forecast for its fiscal year ending in December 2025 is $-1.83, marking a 12.27% increase from the reported $-1.63 in 2024. Estimates for the following years are $-1.64 in 2026, $-1.9 in 2027, and $-1.7 in 2028.

What is Werewolf Therapeutics’s revenue forecast?

Werewolf Therapeutics's average annual revenue forecast for its fiscal year ending in December 2025 is $2.52M, reflecting a 33.82% increase from the reported $1.88M in 2024. The forecast for 2026 is $16.67M, followed by $11.6M for 2027, and $73.09M for 2028.

What is Werewolf Therapeutics’s net income forecast?

Werewolf Therapeutics's net income forecast for the fiscal year ending in December 2025 stands at $-100M, representing an 42.35% increase from the reported $-70.515M in 2024. Projections indicate $-73.603M in 2026, $-80.48M in 2027, and $-60.688M in 2028.